CEI's EnSight 2.0 Available Today (Business Wire)
Read more: CEI's EnSight 2.0 Available Today (Business Wire)
Research and Markets: Astellas Pharma: Performance, Products, Pipeline and Potential Out Now (Business Wire)
Original post: Research and Markets: Astellas Pharma: Performance, Products, Pipeline and Potential Out Now (Business Wire)
ENSTOR Begins Non-Binding Open Season for Facility Under Development (Business Wire)
Read more: ENSTOR Begins Non-Binding Open Season for Facility Under Development (Business Wire)
Research and Markets: Eli Lilly: Pipeline, Products, Performance and Potential 2010 - Lilly's Top Selling Product Is Zyprexa Had Sales in 2008 of Over US$4.6 Billion (Business Wire)
DUBLIN----Research and Markets has announced the addition of the "Eli Lilly: Pipeline, Products, Performance and Potential" company profile to their offering.
Shell, IBM to find ways to extend oil field life (AP)
More here: Shell, IBM to find ways to extend oil field life (AP)
Yale Samples 10M Averaging 1.94% Cu, 19.17% Zn, 0.93% Pb, 36.7 G/T Ag and 0.59 g/t Au at Carol (Business Wire)
Read more: Yale Samples 10M Averaging 1.94% Cu, 19.17% Zn, 0.93% Pb, 36.7 G/T Ag and 0.59 g/t Au at Carol (Business Wire)
Croc shares drop after news of CEO's departure (AP)
Here is the original: Croc shares drop after news of CEO's departure (AP)
Cimarex raises quarterly dividend to 8 cents (AP)
Read more from the original source: Cimarex raises quarterly dividend to 8 cents (AP)
Encore Wire Extends and Expands Stock Repurchase Authorization (Business Wire)
Originally posted here: Encore Wire Extends and Expands Stock Repurchase Authorization (Business Wire)
Vital Images shares rise on Oppenheimer upgrade (AP)
Read the original here: Vital Images shares rise on Oppenheimer upgrade (AP)